ATLAS / Macro Radar / Reporting / CLDI

Calidi Biotherapeutics, Inc. (CLDI) reporting calendar

Calidi Biotherapeutics, Inc. files periodic reports with the SEC as CLDI on NYSE. Atlas tracks 19 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
19 Jul 2026 – 7 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
19

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CLDI market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll NYSE reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001493152-26-023140
10-K31 Dec 202527 Mar 202686 days0001493152-26-013242
10-Q30 Sep 202513 Nov 202544 days0001493152-25-022372
10-Q30 Jun 20258 Aug 202539 days0001641172-25-022797
10-Q31 Mar 202514 May 202544 days0001641172-25-010317
10-K31 Dec 202431 Mar 202590 days0001641172-25-001810
10-Q30 Sep 202412 Nov 202443 days0001493152-24-044833
10-Q30 Jun 202413 Aug 202444 days0001493152-24-031688
10-Q31 Mar 202414 May 202444 days0001493152-24-019305
10-K31 Dec 202315 Mar 202475 days0001493152-24-010158
10-Q30 Sep 202314 Nov 202345 days0001493152-23-041122
10-Q30 Jun 202321 Aug 202352 days0001193125-23-217072
10-Q31 Mar 202315 May 202345 days0001193125-23-145095
10-K31 Dec 202231 Mar 202390 days0001193125-23-088349
10-Q30 Sep 202214 Nov 202245 days0001193125-22-282874
10-Q30 Jun 202210 Aug 202241 days0001193125-22-216531
10-Q31 Mar 202211 May 202241 days0001193125-22-146662
10-K31 Dec 202131 Mar 202290 days0001193125-22-090215
10-Q30 Sep 202112 Nov 202143 days0001193125-21-328181

Source: SEC EDGAR company submissions for CIK 0001855485. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.